1st drug for rare rapid-aging disease extends kids’ lives

The first drug was approved Friday for a rare genetic disorder that stunts growth and causes rapid aging in children, after studies showed it can extend their lives. Kids with the genetic disorder progeria typically die in their early teens, usually from heart disease. But in testing, children taking the drug Zokinvy lived 2 1/2 years longer on average. The U.S. Food and Drug Administration approved the capsules for progeria and a related…